STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
263.85
+10.41 (4.11%)
Nov 13, 2026, 2:35 PM EST - Market open
STERIS Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 6,166 | 5,936 | 5,460 | 5,139 | 4,536 | 4,223 | |
Revenue Growth | 8.13% | 8.73% | 6.24% | 13.28% | 7.41% | 35.91% |
Cost of Revenue | 3,435 | 3,310 | 3,041 | 2,902 | 2,556 | 2,340 |
Gross Profit | 2,731 | 2,626 | 2,419 | 2,236 | 1,981 | 1,883 |
Selling, General & Admin | 1,430 | 1,402 | 1,323 | 1,227 | 1,070 | 1,117 |
Research & Development | 118.5 | 112.9 | 107.6 | 103.7 | 98.48 | 86.66 |
Operating Expenses | 1,548 | 1,514 | 1,431 | 1,331 | 1,169 | 1,203 |
Operating Income | 1,183 | 1,111 | 988.2 | 905.9 | 811.97 | 679.77 |
Interest Expense | -56.9 | -60.7 | -86.3 | -144.4 | -107.96 | -89.49 |
Interest & Investment Income | 12.5 | 9.8 | 8.4 | 11 | - | 6.28 |
Other Non Operating Income (Expenses) | -2 | -3.8 | -0.8 | - | -2.88 | - |
EBT Excluding Unusual Items | 1,136 | 1,057 | 909.5 | 772.5 | 701.14 | 596.56 |
Merger & Restructuring Charges | -35.8 | -9.6 | -73.4 | -69.8 | -23.97 | -201.95 |
Gain (Loss) on Sale of Investments | 0.2 | 0.2 | 0.9 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 7.4 | - | - | - |
Legal Settlements | - | - | -48.2 | - | - | - |
Other Unusual Items | 23 | - | - | - | 3.1 | -27.81 |
Pretax Income | 1,124 | 1,047 | 796.2 | 702.7 | 680.27 | 366.8 |
Income Tax Expense | 294.1 | 262.2 | 184.7 | 149.5 | 124.07 | 82.34 |
Earnings From Continuing Operations | 829.7 | 785.1 | 611.5 | 553.2 | 556.2 | 284.46 |
Earnings From Discontinued Operations | - | - | 4.5 | -173.2 | -450.38 | -41.59 |
Net Income to Company | 829.7 | 785.1 | 616 | 380 | 105.81 | 242.87 |
Minority Interest in Earnings | -2.8 | -2.8 | -1.4 | -1.8 | 1.22 | 1.02 |
Net Income | 826.9 | 782.3 | 614.6 | 378.2 | 107.03 | 243.89 |
Net Income to Common | 826.9 | 782.3 | 614.6 | 378.2 | 107.03 | 243.89 |
Net Income Growth | 20.12% | 27.29% | 62.51% | 253.36% | -56.12% | -38.63% |
Shares Outstanding (Basic) | 98 | 98 | 99 | 99 | 100 | 98 |
Shares Outstanding (Diluted) | 98 | 99 | 99 | 99 | 100 | 98 |
Shares Change | -0.71% | -0.40% | -0.30% | -0.84% | 1.95% | 14.47% |
EPS (Basic) | 8.46 | 7.97 | 6.23 | 3.83 | 1.07 | 2.50 |
EPS (Diluted) | 8.42 | 7.93 | 6.21 | 3.81 | 1.07 | 2.48 |
EPS Growth | 20.79% | 27.79% | 62.98% | 256.78% | -56.92% | -46.50% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 937.2 | 972.4 | 778 | 613 | 394.98 | 397.25 |
Free Cash Flow Per Share | 9.55 | 9.85 | 7.85 | 6.17 | 3.94 | 4.04 |
Dividend Per Share | 2.580 | 2.460 | 2.230 | 2.030 | 1.840 | 1.690 |
Dividend Growth | 10.26% | 10.31% | 9.85% | 10.33% | 8.88% | 7.64% |
Gross Margin | 44.30% | 44.24% | 44.31% | 43.52% | 43.66% | 44.59% |
Operating Margin | 19.18% | 18.72% | 18.10% | 17.63% | 17.90% | 16.10% |
Profit Margin | 13.41% | 13.18% | 11.26% | 7.36% | 2.36% | 5.78% |
Free Cash Flow Margin | 15.20% | 16.38% | 14.25% | 11.93% | 8.71% | 9.41% |
EBITDA | 1,678 | 1,598 | 1,460 | 1,331 | 1,235 | 1,112 |
EBITDA Margin | 27.21% | 26.92% | 26.74% | 25.89% | 27.21% | 26.33% |
D&A For EBITDA | 495.1 | 486.5 | 471.5 | 424.6 | 422.53 | 432.15 |
EBIT | 1,183 | 1,111 | 988.2 | 905.9 | 811.97 | 679.77 |
EBIT Margin | 19.18% | 18.72% | 18.10% | 17.63% | 17.90% | 16.10% |
Effective Tax Rate | 26.17% | 25.04% | 23.20% | 21.27% | 18.24% | 22.45% |
Revenue as Reported | 6,166 | 5,936 | 5,460 | 5,139 | 4,536 | 4,223 |
Advertising Expenses | - | 20.3 | 19.9 | 25.5 | 21.67 | 15.6 |